Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496625 · ClinicalTrials.gov registry record
National Eye Institute Biorepository for Retinal Diseases
A clinical trial of Age-related Macular Degeneration and Diabetic Retinopathy, sponsored by National Eye Institute (NEI).
- Recruiting
- Registry status
- 650
- Enrollment target
- 1
- Study location
NCT01496625 is a study of Age-related Macular Degeneration and Diabetic Retinopathy that is actively recruiting participants, run by National Eye Institute (NEI). The registered enrollment target is 650 participants, below the 1,499-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01496625, a study of Age-related Macular Degeneration and Diabetic Retinopathy, is actively recruiting participants, sponsored by National Eye Institute (NEI).
- RECRUITING
- Registry status
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not, or why some people respond to treatment while others do not. Researchers want to collect physical samples and personal data to develop a National Eye Institute database. Objectives: \- To collect health information and blood and tissue samples from people with and without eye diseases, to be used in research studies. Eligibility: * Individuals at least 2 years of age with different types of eye disease. * Healthy volunteers with no history of eye disease. Design: * Participants may be recruited from National Eye Institute studies or may be referred from other sources. * Participants will be screened with a physical exam and medical history. They will also have a full eye exam. Questions will be asked about family medical history, especially about eye disease. * Blood samples will be collected. Other samples, such as saliva, tears, hair, stool, and urine, may be collected as needed. Adult participants may also provide a skin sample. * Tissue or fluid from eye collected as part of eye care or treatment may also be added to the database. * No treatment will be provided as part of this study.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2012-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01496625
The ClinicalTrials.gov registry entry for NCT01496625 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,499-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (57% lower). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 0 interventions.
NCT01496625 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01496625 about?
NCT01496625 is a clinical study titled "National Eye Institute Biorepository for Retinal Diseases". Background: \- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying gene...
What is the current status of trial NCT01496625?
This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2012-06-18.
What conditions does trial NCT01496625 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Retinal Disease, Retinal Vein Occlusion, Von Hippel-Lindau Syndrome.
Who is sponsoring clinical trial NCT01496625?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01496625 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.